Welgus Howard G. bought ARQT
October 15, 2026 · Form 4 insider transaction
Welgus Howard G. bought 1,018 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $7.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,018
Price
$7.51
Total value
$7.6K
InsiderWelgus Howard G.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 15, 2026
Filing dateOctober 19, 2026
Shares owned after37,681
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027.